Las Vegas, NV

search

Understand Risks Sooner to Personalize Care
and Improve Member Experience

  • October 22, 2021
  • 1:00 PM – 2:00 PM ET
  • Online
about

Fluctuating member populations, information gaps, and growing health inequities make it challenging for health insurance providers to immediately identify risk, improve health, and manage health care costs for their members. Health insurance providers need help identifying more at-risk members sooner, improving the member experience, managing high-risk members with the right interventions at the right time, strengthening physician relationships and engagement, and increasing member engagement regarding their care and health.

This webinar will draw on industry expert knowledge and discussion of a real-world case study to describe how lab data and predictive analytics can be used to understand disease history and future risk of new/existing members prior to their first claim to prioritize personalized care and enhance member experience.

Attendees will learn about:

  • The impact of lab data and predictive analytics on understanding disease history and future risk of new/existing members
  • How data insights can be used to prioritize the delivery of personalized care and enhance member experience prior to the first claims being filed
  • Learnings from a leading chronic kidney disease (CKD) medical expert on using lab data insights to support and inform member risks and care coordination strategies

Speakers


Harvey Kaufman, MD
Senior Medical Director
Quest Diagnostics

Dr. Harvey Kaufman is a Senior Medical Director, Medical Informatics at Quest Diagnostics. In that capacity Harvey leads the Information Ventures health informatics analyst team. He also leads Quest’s Health Trends efforts.

Harvey joined the company in 1992 as Medical Director in Cambridge, Massachusetts. He was the first Chief Laboratory Officer for Quest Diagnostics, the first Six Sigma Quality leader and the first medical director of Hospital Services, Business Development, International and Clinical Trials, as well as Health and Wellness. Harvey has been involved with Quest Diagnostics Health Trends™ since its inception in 2005 and has provided medical support for many of our informatics activities.

He earned a medical degree from the Boston University School of Medicine, a master’s degree in molecular biology from MIT and an MBA in marketing from NYU’s Stern School of Business


Matt Cardoso
Senior Director, Product Solutions for Health Plans
Quest Diagnostics

Matt Cardoso is the Senior Director of Product Solutions for Health Plans at Quest Diagnostics.  He has been with the company’s Healthcare Analytics Solutions franchise since 2016 and in this time, has worked to develop a portfolio of products and solutions that provide the market with analytics based solutions that solve problems in the Health Plan and Health Systems market. Prior to joining Quest, Matt held a variety of leadership positions in product management, product strategy and strategic sales for leading population health, EHR, HIE vendors, and health care delivery networks.

Matt earned a BS. in Biology and BA in Economics from UMass Amherst, as well as an MBA and MS in Health Informatics from Northeastern University.


Teddy Cha
CEO and Co-Founder
pulseData

Teddy Cha is the CEO and Co-Founder of pulseData, data intelligence for chronic disease management. In 1999, Teddy left Wall Street to rent a garage and build a chat app, which was a great product but terrible business. He’s been starting and leading high-growth, enterprise software product teams ever since. In 2015 he reunited with his cofounder Hai Po, a classmate and good friend from undergrad at MIT, and discovered what is possible with health care data – predicting costly acute events from a messy, giant data set, with an opportunity to help eliminate predictable sickness.


Navdeep Tangri, MD, PhD, FRCP(C)
Chronic Disease Innovation Center
University of Manitoba – Winnipeg

Dr. Tangri is an attending physician and Associate Professor in the Division of Nephrology, Department of Medicine and the Department of Community Health Sciences at the University of Manitoba. Dr. Tangri’s research program is clinical and translational and focused on improving clinical decision making for patients with advanced chronic kidney disease. He developed and validated the Kidney Failure Risk Equation (KFRE) to predict the need for dialysis in patients with CKD and is presently engaged in multiple validation and implementation exercises to increase the uptake of the KFRE.

In addition, Dr. Tangri is conducting a large prospective study on frailty, physical and cognitive function in advanced CKD, as well as leading a multinational randomized trial on the safety and efficacy of a new therapy in this population. He has published over 200 manuscripts and presented at multiple national and international scientific meetings and is a recipient of the CIHR New Investigator Award and a CIHR Foundation grant.